Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P5XM
|
|||
| Former ID |
DIB011620
|
|||
| Drug Name |
SM04755
|
|||
| Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 1 | [1] | |
| Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0] | Phase 1 | [2] | ||
| Company |
Samumed
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Wnt signaling pathway (Wnt pathway) | Target Info | Modulator | [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02191761) Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | A Phase 1, Open-Label, Dose-Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects with Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.